{"date":"2025-10-27","count":22,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6949-2025-10-27-1904-ekwdu3","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2025-10-27","time":"19:04:04","subject":"公告本公司114年度第三季合併財務報告董事會召開日期","clause":"第31款","fact_date":"2025-10-27","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2025-10-27 19:04，「公告本公司114年度第三季合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2025-10-27-1903-lofgmk","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2025-10-27","time":"19:03:12","subject":"公告本公司114年第三季合併財務報告預計經董事會決議日","clause":"第31款","fact_date":"2025-10-27","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2025-10-27 19:03，「公告本公司114年第三季合併財務報告預計經董事會決議日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6875-2025-10-27-1802-1lla4j8","company_id":"6875","company":"國邑*","market":"上櫃","industry":"生技醫療","date":"2025-10-27","time":"18:02:09","subject":"公告本公司114年第3季財務報告董事會召開日期","clause":"第31款","fact_date":"2025-10-27","cite_as":"公開資訊觀測站重大訊息：國邑*（6875），2025-10-27 18:02，「公告本公司114年第3季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6808-2025-10-27-1754-1v89vf8","company_id":"6808","company":"三鼎生技","market":"興櫃","industry":"生技醫療","date":"2025-10-27","time":"17:54:48","subject":"公告本公司買回庫藏股期間屆滿執行情形","clause":"第41款","fact_date":"2025-10-27","cite_as":"公開資訊觀測站重大訊息：三鼎生技（6808），2025-10-27 17:54，「公告本公司買回庫藏股期間屆滿執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6550-2025-10-27-1750-1jdf3l1","company_id":"6550","company":"北極星藥業-KY","market":"上市","industry":"生技醫療","date":"2025-10-27","time":"17:50:43","subject":"【補正】公告本公司董事會決議通過召開114年第一次股東臨時會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：北極星藥業-KY（6550），2025-10-27 17:50，「【補正】公告本公司董事會決議通過召開114年第一次股東臨時會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4183-2025-10-27-1750-16mq1wu","company_id":"4183","company":"福永生技","market":"上櫃","industry":"生技醫療","date":"2025-10-27","time":"17:50:32","subject":"114年第三季財務報告董事會預計召開日期為114年11月05日","clause":"第31款","fact_date":"2025-10-27","cite_as":"公開資訊觀測站重大訊息：福永生技（4183），2025-10-27 17:50，「114年第三季財務報告董事會預計召開日期為114年11月05日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2025-10-27-1746-p3l3cc","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2025-10-27","time":"17:46:08","subject":"本公司法人董事改派代表人","clause":"第6款","fact_date":"2025-10-27","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2025-10-27 17:46，「本公司法人董事改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2025-10-27-1732-5lrh5b","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2025-10-27","time":"17:32:08","subject":"公告本公司董事會通過解除經理人競業禁止之限制案","clause":"第21款","fact_date":"2025-10-27","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2025-10-27 17:32，「公告本公司董事會通過解除經理人競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2025-10-27-1731-itqmci","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2025-10-27","time":"17:31:45","subject":"公告本公司董事會決議庫藏股轉讓員工並訂定認股基準日","clause":"第53款","fact_date":"2025-10-27","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2025-10-27 17:31，「公告本公司董事會決議庫藏股轉讓員工並訂定認股基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2025-10-27-1728-1mo4xb0","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2025-10-27","time":"17:28:03","subject":"本公司生物藥品「益康平凍晶注射劑420毫克(EIRGASUN vial 420 mg)」已接獲台灣衛生福利部核准函","clause":"第10款","fact_date":"2025-10-27","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2025-10-27 17:28，「本公司生物藥品「益康平凍晶注射劑420毫克(EIRGASUN vial 420 mg)」已接獲台灣衛生福利部核准函」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6242-2025-10-27-1659-yro08j","company_id":"6242","company":"立康","market":"上櫃","industry":"生技醫療","date":"2025-10-27","time":"16:59:24","subject":"公告114年第3季合併財務報告董事會召開日期","clause":"第31款","fact_date":"2025-10-27","cite_as":"公開資訊觀測站重大訊息：立康（6242），2025-10-27 16:59，「公告114年第3季合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4905-2025-10-27-1644-17ivmmf","company_id":"4905","company":"台聯電","market":"上櫃","industry":"生技醫療","date":"2025-10-27","time":"16:44:08","subject":"公告本公司114年第三季合併財務報告董事會召開日期","clause":"第31款","fact_date":"2025-10-27","cite_as":"公開資訊觀測站重大訊息：台聯電（4905），2025-10-27 16:44，「公告本公司114年第三季合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2025-10-27-1643-bw8g9","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2025-10-27","time":"16:43:50","subject":"本公司受邀參加第一金證券舉辦之實體法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2025-10-27 16:43，「本公司受邀參加第一金證券舉辦之實體法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2025-10-27-1643-1gym387","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2025-10-27","time":"16:43:21","subject":"公告本公司董事會決議辦理初次上櫃前現金增資發行新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2025-10-27 16:43，「公告本公司董事會決議辦理初次上櫃前現金增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2025-10-27-1620-eub3g5","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2025-10-27","time":"16:20:35","subject":"公告本公司今日接獲註冊代理人通知，阿根廷國家藥品、食品與醫療器材管理局(ANMAT)受理Bonvadis外用乳膏完全傷口適應症醫材產品註冊申請","clause":"第10款","fact_date":"2025-10-27","cite_as":"公開資訊觀測站重大訊息：合一（4743），2025-10-27 16:20，「公告本公司今日接獲註冊代理人通知，阿根廷國家藥品、食品與醫療器材管理局(ANMAT)受理Bonvadis外用乳膏完全傷口」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2025-10-27-1617-zx98rx","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2025-10-27","time":"16:17:39","subject":"公告本公司「經修飾的巨噬細胞、其組成物及其用途」取得俄羅斯發明專利","clause":"第44款","fact_date":"2025-10-27","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2025-10-27 16:17，「公告本公司「經修飾的巨噬細胞、其組成物及其用途」取得俄羅斯發明專利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6491-2025-10-27-1503-1dbo2tp","company_id":"6491","company":"晶碩","market":"上市","industry":"生技醫療","date":"2025-10-27","time":"15:03:36","subject":"公告本公司於董事會通過民國一一四年度第三季合併財務報告","clause":"第31款","fact_date":"2025-10-27","cite_as":"公開資訊觀測站重大訊息：晶碩（6491），2025-10-27 15:03，「公告本公司於董事會通過民國一一四年度第三季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6785-2025-10-27-1450-70bzw","company_id":"6785","company":"昱展新藥","market":"上櫃","industry":"生技醫療","date":"2025-10-27","time":"14:50:54","subject":"公告本公司收到「KETAMINE PAMOATE AND USE THEREOF」韓國專利核准通知書。","clause":"第53款","fact_date":"2025-10-27","cite_as":"公開資訊觀測站重大訊息：昱展新藥（6785），2025-10-27 14:50，「公告本公司收到「KETAMINE PAMOATE AND USE THEREOF」韓國專利核准通知書。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4111-2025-10-27-1448-atdisk","company_id":"4111","company":"濟生","market":"上櫃","industry":"生技醫療","date":"2025-10-27","time":"14:48:35","subject":"公告114年第三季財務報告董事會預計召開日期為114年11月5日","clause":"第31款","fact_date":"2025-10-27","cite_as":"公開資訊觀測站重大訊息：濟生（4111），2025-10-27 14:48，「公告114年第三季財務報告董事會預計召開日期為114年11月5日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6762-2025-10-27-1346-1svqzfe","company_id":"6762","company":"達亞","market":"上櫃","industry":"生技醫療","date":"2025-10-27","time":"13:46:47","subject":"公告本公司114年第三季財務報告經審計委員會同意，並提董事會決議通過","clause":"第31款","fact_date":"2025-10-27","cite_as":"公開資訊觀測站重大訊息：達亞（6762），2025-10-27 13:46，「公告本公司114年第三季財務報告經審計委員會同意，並提董事會決議通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8409-2025-10-27-1136-j91z71","company_id":"8409","company":"商之器","market":"上櫃","industry":"生技醫療","date":"2025-10-27","time":"11:36:52","subject":"公告本公司114年第三季財務報告提董事會決議日期","clause":"第31款","fact_date":"2025-10-27","cite_as":"公開資訊觀測站重大訊息：商之器（8409），2025-10-27 11:36，「公告本公司114年第三季財務報告提董事會決議日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6875-2025-10-27-0608-1k9k9gf","company_id":"6875","company":"國邑*","market":"上櫃","industry":"生技醫療","date":"2025-10-27","time":"06:08:24","subject":"本公司吸入新藥L608臨床一期試驗成果於2025年美國風濕學會(ACR 2025)發表，展示其在SSc-DU治療中的潛力","clause":"第53款","fact_date":"2025-10-26","cite_as":"公開資訊觀測站重大訊息：國邑*（6875），2025-10-27 06:08，「本公司吸入新藥L608臨床一期試驗成果於2025年美國風濕學會(ACR 2025)發表，展示其在SSc-DU治療中的潛力」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}